We are a leading international consumer healthcare business
An primoraof people, partners and brands, working together to achieve more
About primoraBuilding primoras for better healthcare
Partnering with healthcare professionals worldwide to deliver trusted solutions
About primoraTrusted brands reaching patients globally
Delivering proven healthcare solutions to over 100 countries worldwide
About primoraInnovative products for everyday health
From dermatology to nutrition, our brands make a difference in peoples lives
About primoraRealising potential
Brands achieve more with Primora.
Spinal muscular atrophy (SMA) treatment has been revolutionized by three FDA-approved disease-modifying therapies—Nusinersen (Spinraza), Risdiplam (Evrysdi), and Onasemnogene abeparvovec (Zolgensma)—which target the underlying genetic cause by increasing survival motor neuron (SMN) protein production. These, combined with supportive care like physical therapy and respiratory support, significantly improve motor function and survival, especially when initiated early.
Help your scar fade to feel your confidence grow.
KELO-COTE™ is an advanced formula silicone treatment which helps improve the appearance of hypertrophic and keloid scars and helps prevent them from forming.
Kelo-Cote™
Nizoral™ a medicated anti-dandruff shampoo.
Nizoral™ kills the fungus that can cause itchy, flaky scalps and dandruff. primora's association with the NIZORAL™ Shampoo brand is only applicable to APAC territories.
Nizoral™
Our trusted brands
Delivering proven healthcare solutions across multiple therapeutic categories
BUILDING primoraS
Partners achieve more with Primora.
Building new partnerships enables us to achieve things that otherwise wouldn't be possible.
Our strategyGROWING TOGETHER
People achieve more with Primora.
We know that working together brings a better outcome.
Join usNatalie's career journey
Realising your potential
Assessing opportunities...
Achieving more
How we delivered for our shareholders in 2024
Expanded gross margin. Increased investment behind our key brands
Maintained underlying group profit
Strengthened the skills, experience and expertise on the Executive Committee to align with the long term strategy
Commenced work to adapt the Company's culture and capabilities to support our ambition to become a high-performing Consumer Healthcare Company
Good progress made with developing and executing our sustainability strategy
Industry Insights
The Global Pharmaceutical Industry
The pharmaceutical industry is one of the world's most vital sectors, dedicated to researching, developing, and distributing medications that improve and save lives. With a global market value exceeding $1.5 trillion, it continues to grow driven by innovation, aging populations, and increasing healthcare awareness.
Consumer healthcare, our core focus, represents a rapidly expanding segment as people increasingly take proactive control of their health and wellness through over-the-counter products, supplements, and preventive care solutions.
Countries Served
Annual Industry Growth
People Reached Annually
Products in Development
Market Dynamics
Key Industry Trends Driving Growth
Understanding the forces shaping the future of healthcare and pharmaceuticals
Aging Population
By 2050, the global population aged 60+ will double to 2.1 billion, driving unprecedented demand for healthcare products and chronic disease management solutions.
Self-Care Revolution
Consumers are increasingly taking control of their health with OTC products, supplements, and preventive care, creating a $450B+ consumer healthcare market.
Personalized Medicine
Advances in genomics and biotechnology are enabling tailored treatments, with gene therapies like Zolgensma revolutionizing disease management.
Emerging Markets
Rising middle classes in Asia, Africa, and Latin America are expanding healthcare access, with emerging markets growing at 2x the rate of developed regions.
Digital Health
E-commerce, telemedicine, and digital therapeutics are transforming how consumers access and purchase healthcare products globally.
Sustainability Focus
Environmental responsibility is becoming essential, with consumers and regulators demanding sustainable packaging, ethical sourcing, and carbon-neutral operations.
Why Choose Primora
Benefits of Partnering With Us
Discover why leading pharmaceutical companies and healthcare brands choose Primora as their strategic partner
Global Distribution Network
Access to established distribution channels across 100+ countries, ensuring your products reach patients worldwide efficiently.
Brand Growth Expertise
Proven track record of acquiring and growing healthcare brands, maximizing market potential through strategic marketing and positioning.
Regulatory Excellence
Deep expertise in navigating complex regulatory environments across multiple jurisdictions, ensuring compliance and market access.
Financial Stability
Strong balance sheet and consistent profitability provide the foundation for long-term partnerships and sustainable growth.
Experienced Leadership
Management team with decades of combined experience in pharmaceutical commercialization, M&A, and brand development.
Dedicated Partner Support
Personalized account management and responsive support teams ensure seamless collaboration and rapid issue resolution.
Innovation Focus
Continuous investment in new therapeutic areas and product development, staying ahead of market trends and patient needs.
Sustainability Commitment
ESG-focused operations with clear sustainability targets, aligning with modern stakeholder expectations and regulatory requirements.
Investor Relations
Invest in Healthcare Excellence
Primora Pharmaceutical offers investors exposure to the resilient and growing consumer healthcare sector. Our diversified portfolio, global reach, and disciplined capital allocation create sustainable long-term value.
Revenue FY2024
Gross Margin
Dividend Per Share
Years Listed
Investment Case
Why Invest in Primora
Resilient Business
Healthcare demand remains stable regardless of economic cycles, providing defensive characteristics for investors.
Diversified Portfolio
Multiple brands across therapeutic categories and geographies reduce concentration risk and drive stable returns.
Growth Potential
Strategic acquisitions and organic brand development create multiple pathways for revenue and profit growth.
Shareholder Returns
Commitment to progressive dividends and disciplined capital allocation maximizes shareholder value creation.
Stay Informed
Subscribe to our investor alerts to receive the latest financial results, regulatory announcements, and company news directly to your inbox.
Listed on AIM
LON: APH